Literature DB >> 15959950

Future of COX2 inhibitors.

Irena Melnikova.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15959950     DOI: 10.1038/nrd1755

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  5 in total

1.  Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production.

Authors:  Marion Man-Ying Chan; Andrea Rossi Moore
Journal:  J Immunol       Date:  2010-04-30       Impact factor: 5.422

2.  Cytomics, the human cytome project and systems biology: top-down resolution of the molecular biocomplexity of organisms by single cell analysis.

Authors:  G Valet
Journal:  Cell Prolif       Date:  2005-08       Impact factor: 6.831

3.  Anti-inflammatory properties of prostaglandin E2: deletion of microsomal prostaglandin E synthase-1 exacerbates non-immune inflammatory arthritis in mice.

Authors:  Andrey Frolov; Lihua Yang; Hua Dong; Bruce D Hammock; Leslie J Crofford
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2013-08-30       Impact factor: 4.006

4.  Molecular modelling insights into a physiologically favourable approach to eicosanoid biosynthesis inhibition through novel thieno[2,3-b]pyridine derivatives.

Authors:  Mosaad S Mohamed; Yara E Mansour; Hatem K Amin; Moustafa E El-Araby
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

Review 5.  Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing.

Authors:  Afaf A El-Malah; Magdy M Gineinah; Pran Kishore Deb; Ahdab N Khayyat; Monika Bansal; Katharigatta N Venugopala; Anfal S Aljahdali
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.